Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppina M Carbone

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
European Urology Oncology|August 13, 2019
Efficacy of Novel Bromodomain and Extraterminal Inhibitors in Combination with Chemotherapy for Castration-Resistant Prostate CancerRamiro Vázquez, Gianluca Civenni, Aleksandra Kokanovic, et al.
Genes|October 28, 2023
Detection of Cancer-Associated Gene Mutations in Urinary Cell-Free DNA among Prostate Cancer Patients in South AfricaDada Oluwaseyi Temilola, Martha Wium, Juliano Paccez, et al.
Cancers|October 17, 2020
Erratum: Mapelli, S.N., et al. A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors). <i>Cancers</i> 2020, <i>12</i>, 176Sarah N Mapelli, Domenico Albino, Maurizia Mello-Grand, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2017
Mitochondrial dysfunction induced by a SH2 domain-targeting STAT3 inhibitor leads to metabolic synthetic lethality in cancer cellsDavide Genini, Lara Brambilla, Erik Laurini, et al.
Cancers|January 16, 2020
A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors)Sarah N Mapelli, Domenico Albino, Maurizia Mello-Grand, et al.
Cancer Research|May 20, 2016
Activation of the Lin28/let-7 Axis by Loss of ESE3/EHF Promotes a Tumorigenic and Stem-like Phenotype in Prostate CancerDomenico Albino, Gianluca Civenni, Cecilia Dallavalle, et al.
Nucleic Acids Research|March 31, 2006
Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapyVeronica Albertini, Aklank Jain, Sara Vignati, et al.
Cancer Research|April 17, 2012
ESE3/EHF controls epithelial cell differentiation and its loss leads to prostate tumors with mesenchymal and stem-like featuresDomenico Albino, Nicole Longoni, Laura Curti, et al.
European Urology Oncology|July 7, 2019
Transcriptional Reprogramming and Inhibition of Tumor-propagating Stem-like Cells by EC-8042 in ERG-positive Prostate CancerDheeraj Shinde, Domenico Albino, Marita Zoma, et al.
Cancer & Metabolism|August 4, 2021
Inflammatory metabolic profile of South African patients with prostate cancerStefano Cacciatore, Martha Wium, Cristina Licari, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
European Urology Oncology|August 13, 2019
Efficacy of Novel Bromodomain and Extraterminal Inhibitors in Combination with Chemotherapy for Castration-Resistant Prostate CancerRamiro Vázquez, Gianluca Civenni, Aleksandra Kokanovic, et al.
Genes|October 28, 2023
Detection of Cancer-Associated Gene Mutations in Urinary Cell-Free DNA among Prostate Cancer Patients in South AfricaDada Oluwaseyi Temilola, Martha Wium, Juliano Paccez, et al.
Cancers|October 17, 2020
Erratum: Mapelli, S.N., et al. A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors). <i>Cancers</i> 2020, <i>12</i>, 176Sarah N Mapelli, Domenico Albino, Maurizia Mello-Grand, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2017
Mitochondrial dysfunction induced by a SH2 domain-targeting STAT3 inhibitor leads to metabolic synthetic lethality in cancer cellsDavide Genini, Lara Brambilla, Erik Laurini, et al.
Cancers|January 16, 2020
A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors)Sarah N Mapelli, Domenico Albino, Maurizia Mello-Grand, et al.
Cancer Research|May 20, 2016
Activation of the Lin28/let-7 Axis by Loss of ESE3/EHF Promotes a Tumorigenic and Stem-like Phenotype in Prostate CancerDomenico Albino, Gianluca Civenni, Cecilia Dallavalle, et al.
Nucleic Acids Research|March 31, 2006
Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapyVeronica Albertini, Aklank Jain, Sara Vignati, et al.
Cancer Research|April 17, 2012
ESE3/EHF controls epithelial cell differentiation and its loss leads to prostate tumors with mesenchymal and stem-like featuresDomenico Albino, Nicole Longoni, Laura Curti, et al.
European Urology Oncology|July 7, 2019
Transcriptional Reprogramming and Inhibition of Tumor-propagating Stem-like Cells by EC-8042 in ERG-positive Prostate CancerDheeraj Shinde, Domenico Albino, Marita Zoma, et al.
Cancer & Metabolism|August 4, 2021
Inflammatory metabolic profile of South African patients with prostate cancerStefano Cacciatore, Martha Wium, Cristina Licari, et al.
Pageof 5